GPT and Sensory neuropathy: The common objective treatment-related AEs observed in this study were rash, fever, abdominal pain, vomiting, fatigue, diarrhea, leukopenia, neutropenia, anemia, thrombocytopenia, elevated ALT, elevated AST, hyperbilirubinemia, hypoalbuminemia, elevated creatinine, and sensory neuropathy.